Full Text
GOVERNMENT OF INDIA
REGD. No. D. L.-33002/99
Delhi Gazette
SG-DL-E-05102024-257719
EXTRAORDINARY
PUBLISHED BY AUTHORITY
No. 246]
DELHI, THURSDAY, OCTOBER 03, 2024/ASVINE 1, 1946
[N. C. T. D. No. 208
PART IV
GOVERNMENT OF THE NATIONAL CAPITAL TERRITORY OF DELHI
6432 DG/2024
(HEALTH AND FAMILY WELFARE DEPARTMENT)
NOTIFICATION
Delhi, the 3rd October, 2024
F. No. 13(112)/Misc./2022/628.—In exercise of the power conferred by sub-section (1) of Section
20 of the Drugs and Cosmetics Act, 1940 (23 of 1940), read with Rule 44 of Drugs Rules, 1945, Rule 7 of
Cosmetics Rules, 2020 and prior consent of the Central Government, the Lt. Governor of the National
Capital Territory of Delhi is pleased to appoint Dr. Anjan Pal, Senior Scientific Officer (Microbiology) &
Dr. Prodipta Sarkar, Associate Biochemist, Central Drugs Laboratory (CDL), Kolkata, Ministry of Health
& Family Welfare, Government of India, as Government Analysts for the National Capital Territory of
Delhi for carrying out the tests and analysis of cosmetics and drugs including those specified in Schedule C
and C-1 of the Drugs Rules, 1945, except for classes of drugs mentioned below, namely: -
(i) Sera;
(ii) Solution of Serum Proteins intended for injections;
(iii) Vaccines (Parenteral & Oral);
(iv) Toxins;
(v) Antigen;
(vi) Anti-toxins;
(vii) Sterilized Surgical Ligatures and Sterilized Surgical Sutures;
(viii) Bacteriophages;
(ix) Anti-Sera for veterinary use;
(x) Vaccines for veterinary use;
(xi) Toxoid for veterinary use;
(xii) Diagnostic Antigens for veterinary use;
(xiii) VDRL Antigen;
(xiv) Intra-Uterine Devices and Folope Rings;
(xv) Human Blood and Human Blood Products;
(xvi) Blood Grouping reagents and diagnostic kits for Human Immunodeficiency Virus. Hepatitis B
Surface Antigen and Hepatitis C virus; and
(xvii) Condom
By Order and in the Name of the Lt. Governor of
the National Capital Territory of Delhi,
RAJENDER KUMAR AHUJA, Dy. Secy.
Login to read full text